Skip to content
MarketScale
Demo
Creator Hubs›GE HealthCare
GE HealthCare logo

Precision care tools built for clinicians and health systems.

GE HealthCare is a global medical technology company focused on precision diagnostics, imaging, and patient monitoring. The company develops hardware, software, and AI-driven tools that help clinicians detect, diagnose, and treat conditions across cardiology, oncology, and radiology. Their MarketScale channel publishes expert content for healthcare decision-makers evaluating clinical and operational technology.

4 episodesVisit website ↗
Channel Brief·GE Healthcare · 4 episodes
Updated Aug 12, 2024

GE Healthcare Builds Clinical Innovation Through Strategic Partnerships

GE HealthCare advances imaging and diagnostics by pairing its technology platforms with academic and health system partners. The content shows how collaboration, data analytics, and targeted molecular imaging drive measurable clinical outcomes.

GE HealthCare's strategy centers on partnership-driven innovation, merging industrial technology with academic and clinical expertise to accelerate product development and operational improvement. The channel documents this thesis through concrete collaborations: a research hub with UC and Cincinnati Children's to advance MRI systems, and a 6-year operational partnership with Navicent Health leveraging analytics for care delivery and cost savings.

Drawn from GE HealthCare & UC Launch the Future of MRI Re… and 1 more →

“Detecting estrogen receptor status in lesions difficult to biopsy through molecular imaging.”

Gary Ulaner, MD, PhD, FACNM on Cerianna estrogen receptor PET-CT

By the numbers

$150m

Forecast savings from Navicent Health partnership

6-year

Duration of Navicent Health partnership with GE HealthCare

What the channel argues

InsightGE HealthCare established MRI Research Center with UC, UC Health, and Cincinnati Children's, featuring SIGNA Premier 3T scanner.→
DataNavicent Health partnership forecast $150m in savings over 6 years using GE HealthCare analytics.→
InsightCerianna estrogen receptor PET-CT, FDA-approved, identifies recurrent and metastatic breast cancer patients via targeted molecular imaging.→
InsightGE HealthCare advances physician decision-making and patient flow through operational analytics platforms.→

What you'll learn

•How GE HealthCare partners with academic medical centers to accelerate MRI innovation through shared R&D infrastructure and expertise.
•The role of targeted molecular imaging in non-invasively detecting estrogen receptor status in difficult-to-biopsy breast cancer lesions.
•Why health systems pursue multi-year analytics partnerships: Navicent Health's 6-year collaboration with GE HealthCare aims to improve care delivery and streamline operations simultaneously.
•GE HealthCare uses AI-enabled imaging systems to address both adult and pediatric clinical needs in research hubs.

What to do about it

→Evaluate whether your health system can benefit from a partnership model combining GE HealthCare analytics with internal clinical operations to improve patient flow and decision-making.
→Assess the clinical utility of targeted molecular imaging like estrogen receptor PET-CT in your oncology workflow for identifying patients suitable for receptor-targeted therapy.
→Explore participation in academic research hubs that pair industrial imaging platforms with institutional expertise to accelerate innovation in your clinical focus areas.

Who and what shows up

Gary Ulaner, MD, PhD, FACNM

Oncologist and molecular imaging specialist

Discussed the clinical mechanism and application of Cerianna estrogen receptor PET-CT for identifying breast cancer patients eligible for receptor-targeted therapy.

University of Cincinnati (UC), UC Health, and Cincinnati Children's

Academic medical institutions

Partnered with GE HealthCare to establish a cutting-edge MRI R&D Center combining academic expertise with industrial innovation on UC's medical campus.

Navicent Health

Georgia-based health system

Partnered with GE HealthCare for a 6-year collaboration to improve care delivery and operations, with forecast $150m in savings through analytics.

Questions this channel answers

Q

How does GE HealthCare accelerate MRI innovation?

By establishing collaborative R&D centers with academic medical institutions and health systems, combining GE HealthCare's technology platforms with institutional clinical expertise.

GE HealthCare & UC Launch the Future of MRI Research →
Q

What is the clinical value of estrogen receptor targeted PET-CT imaging?

It non-invasively detects estrogen receptor status in recurrent or metastatic breast cancer lesions and in lesions difficult to biopsy, informing treatment eligibility decisions.

Cerianna: Advancing Estrogen Receptor Targeted PET-CT fo… →
Q

How do health systems achieve operational savings with GE HealthCare partnerships?

Through analytics platforms that improve care delivery, patient flow, and physician decision-making. Navicent Health's 6-year collaboration forecast $150m in savings.

Watch: Carequality Framework Connects Thousands of Hospi… →
Topics:MRI imaging and R&DMolecular imaging and oncology diagnosticsHealth system analytics and operationsAI software and hardware in medical imagingPediatric and adult clinical applications
Themes:Partnership-driven medical innovationMolecular imaging for precision oncology diagnosticsData analytics as operational lever in health systems

Industry context

The global theranostics market is projected to grow from USD 10.29 billion in 2025 to USD 31.38 billion by 2035, at a compound annual growth rate of 11.8 percent.